Ralph L Sacco Selected Research

Platelet Aggregation Inhibitors (Antiplatelet Drugs)

10/2021	Balancing Benefits and Risks of Long-Term Antiplatelet Therapy in Noncardioembolic Transient Ischemic Attack or Stroke.
1/2019	Antiplatelet Therapy After Noncardioembolic Stroke.
1/2019	Antithrombotic Therapy to Prevent Recurrent Strokes in Ischemic Cerebrovascular Disease: JACC Scientific Expert Panel.
1/2018	Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial).
8/2017	Predicting major bleeding in patients with noncardioembolic stroke on antiplatelets: S2TOP-BLEED.
10/2015	Individual patient data meta-analysis of antiplatelet regimens after noncardioembolic stroke or TIA: rationale and design.
4/2014	Embolic strokes of undetermined source: the case for a new clinical construct.
1/2011	Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association.
6/2008	Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
3/2006	Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ralph L Sacco Research Topics

Disease

138	Stroke (Strokes) 04/2022 - 01/2002
63	Ischemic Stroke 10/2021 - 01/2002
39	Hypertension (High Blood Pressure) 10/2021 - 01/2002
25	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 12/2002
24	Atherosclerosis 06/2022 - 01/2002
16	Diabetes Mellitus 01/2021 - 01/2002
14	Noma (Nomas) 01/2020 - 03/2008
14	Heart Failure 04/2019 - 04/2012
14	Myocardial Infarction 01/2019 - 11/2005
12	Transient Ischemic Attack 01/2022 - 09/2004
11	Inflammation (Inflammations) 01/2019 - 05/2005
10	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2022 - 12/2009
10	Vascular Diseases (Vascular Disease) 11/2017 - 05/2005
10	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2015 - 06/2006
9	Embolic Stroke 01/2022 - 09/2003
9	Hemorrhage 10/2021 - 05/2012
9	Patent Foramen Ovale 01/2021 - 06/2002
9	Carotid Artery Diseases 09/2020 - 01/2002
8	Atrial Fibrillation 01/2021 - 06/2004
7	Obesity 01/2022 - 06/2006
7	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 01/2002
7	Cerebral Hemorrhage 01/2016 - 05/2005
6	Sickle Cell Anemia (Hemoglobin S Disease) 01/2017 - 02/2006
6	Infarction (Infarctions) 04/2014 - 01/2006
6	Hyperhomocysteinemia 01/2011 - 02/2006
5	Dyslipidemias (Dyslipidemia) 01/2022 - 06/2006
5	Cognitive Dysfunction 03/2021 - 10/2008
5	Infections 08/2020 - 06/2006
5	Carotid Stenosis (Carotid Artery Stenosis) 03/2015 - 06/2006
5	Heart Diseases (Heart Disease) 06/2014 - 01/2006
5	Intracranial Sinus Thrombosis (Sinus Thrombosis) 01/2011 - 09/2004
4	Ischemia 10/2021 - 06/2009
4	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2019 - 09/2008
4	Blood Vessel Dissection 10/2014 - 02/2006
4	Peripheral Vascular Diseases (Peripheral Vascular Disease) 05/2013 - 06/2009
4	Coronary Disease (Coronary Heart Disease) 01/2010 - 11/2005
3	Pathologic Constriction (Stenosis) 01/2022 - 10/2021
3	Thrombosis (Thrombus) 10/2021 - 04/2014
3	Embolism (Embolus) 01/2019 - 04/2014
3	Chronic Renal Insufficiency 01/2018 - 05/2014
3	Neoplasms (Cancer) 01/2017 - 12/2012
3	Dementia (Dementias) 01/2017 - 06/2005
3	Insulin Resistance 02/2013 - 10/2010
3	Hypercholesterolemia 01/2013 - 04/2012
3	Atherosclerotic Plaque (Atheroma) 12/2011 - 08/2010

Drug/Important Bio-Agent (IBA)

40	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 06/2002
22	Warfarin (Coumadin)FDA LinkGeneric 04/2019 - 06/2002
21	Biomarkers (Surrogate Marker)IBA 06/2022 - 05/2005
18	LipidsIBA 01/2022 - 01/2002
16	CholesterolIBA 01/2020 - 11/2005
15	Tissue Plasminogen Activator (Alteplase)FDA Link 04/2022 - 09/2004
14	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2021 - 07/2005
13	AnticoagulantsIBA 01/2021 - 01/2002
12	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2021 - 09/2004
12	HDL CholesterolIBA 01/2020 - 01/2002
11	LDL CholesterolIBA 01/2020 - 01/2002
10	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2005
10	Antihypertensive Agents (Antihypertensives)IBA 01/2017 - 01/2002
9	Clopidogrel (Plavix)FDA Link 10/2021 - 09/2004
8	Dipyridamole (Persantine)FDA LinkGeneric 10/2021 - 09/2004
8	C-Reactive ProteinIBA 01/2016 - 10/2006
7	Thrombin FDA Link 01/2022 - 06/2004
6	Dabigatran FDA Link 01/2022 - 12/2015
6	Phenobarbital (Luminal)FDA Link 01/2022 - 08/2015
6	Pharmaceutical PreparationsIBA 01/2018 - 05/2005
6	Hormones (Hormone)IBA 09/2015 - 02/2006
6	Triglycerides (Triacylglycerol)IBA 04/2015 - 01/2002
6	HomocysteineIBA 08/2013 - 10/2004
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2009
5	GenieIBA 01/2021 - 10/2017
5	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2019 - 10/2006
5	CalciumIBA 12/2018 - 10/2007
5	Blood Glucose (Blood Sugar)IBA 04/2013 - 11/2007
5	SodiumIBA 12/2012 - 01/2007
5	Neuroprotective AgentsIBA 10/2008 - 05/2005
4	oxidized low density lipoproteinIBA 01/2022 - 11/2009
4	CreatinineIBA 01/2022 - 11/2009
4	Apolipoproteins E (ApoE)IBA 08/2020 - 08/2015
4	Interleukin-6 (Interleukin 6)IBA 01/2019 - 01/2006
4	ApolipoproteinsIBA 03/2018 - 12/2002
4	ORALIT (ORS)IBA 03/2017 - 07/2003
4	Lipoproteins (Lipoprotein)IBA 10/2015 - 06/2006
4	AdiponectinIBA 08/2013 - 04/2012
4	Apolipoproteins B (ApoB)IBA 08/2010 - 12/2002
4	Lipoprotein(a)IBA 08/2010 - 01/2002
3	Indicators and Reagents (Reagents)IBA 01/2021 - 09/2008
3	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 07/2017 - 01/2002
3	Angiotensin Receptor AntagonistsIBA 01/2017 - 09/2008
3	Phosphates (Orthophosphate)IBA 04/2016 - 05/2014
3	Fibroblast Growth Factor-23IBA 04/2016 - 05/2014
3	SmokeIBA 12/2015 - 06/2006
3	Phospholipases (Phospholipase)IBA 10/2015 - 06/2006
3	Receptor for Advanced Glycation End ProductsIBA 05/2015 - 05/2011
3	Retinaldehyde (Retinal)IBA 10/2014 - 06/2009
3	Telmisartan (Micardis)FDA Link 09/2012 - 09/2008
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 08/2010 - 12/2002

Therapy/Procedure

38	Therapeutics 01/2022 - 01/2002
9	Secondary Prevention 12/2019 - 01/2002
4	Thrombolytic Therapy 10/2016 - 06/2002
3	Transcatheter Aortic Valve Replacement 09/2012 - 04/2012